About MigVax Ltd.

 
Mission and Values

MigVax was established Established in 2020 via a leading investment from OurCrowd, the crowdfunding venture investment platform, MigVax set out to modify a well-established coronavirus vaccine developed by Migal for the immunization of poultry, and to use its advanced methodologies to create its innovative oral subunit vaccine for the immunization of humans, starting with the COVID-19.

 

The COVID-19 vaccine project initiated upon a inter-disciplinary research team successful development of a vaccine against Infectious Bronchitis Virus (IBV), an avian (poultry) Coronavirus with high similarity to today’s human COVID-19 that uses the same infection mechanism.

 

Given the similarity, and following required genetic adjustments, the same vaccination concepts should apply. The inter-disciplinary research group is uniquely qualified to carry out this work. It carries several years of experience in vaccine development projects at MIGAL. 

lior jurnou-9168.jpg
The Team

Management

David Zigdon                         Interim CEO

Prof. Itamar Shalit                SAB Clinical

Rivka Zaibel                           QA/RA Consultant

Roni Pinkus Ph.D.                  Production Consultant

Sigal Tal MD.                          VP Clinical & Regulatory

Ronald Ellis Ph.D.                  CTO

 

Einav Askenazi                      Project Manager

Research

Prof. Jacob Pitcovski            Virology and Poultry Vaccination

Ehud Shahar Ph.D.               Immunology

Itai Bloch                               Computational Chemistry

Itamar Yadid, Ph.D.              Microbial Metabolic Pathways

 

Migal Galilee Research Institute Ltd, an internationally-recognized multi-disciplinary applied research institute located in Israel’s northern Galilee. Migal was established in 1979, and today is addressing the world’s most pressing challenges by research in biotechnology, computer sciences, plant science, precision agriculture and environmental sciences, and food, nutrition and health. Recognized as a powerhouse of applied research, for forty years MIGAL has cooperated closely with industry leaders, innovative startups, and technological accelerators. MIGALs' employees include 90 PhDs and 190 researchers distributed across 44 research groups, operating as an innovative research ecosystem that encourages collaboration across scientific, industrial, agricultural, academic and technological specialties.

 

Logo MIGAL - Copy.png
lior jurnou-9339.jpg